Loading clinical trials...
Loading clinical trials...
A Randomized, Double-Blind Study of Combination Vitamin E, Selenium and Lycopene vs. Placebo in Men Undergoing Radical Prostatectomy for Prostate Cancer
The purpose of this study is to see if an intervention of antioxidants(vitamin E, selenium and lycopene) can change (reduce) prostate tumor size and alter certain markers that can affect tumor growth and prostate cancer aggressiveness.
Age
18 - No limit years
Sex
MALE
Healthy Volunteers
No
University Health Network, Princess Margaret Hospital
Toronto, Ontario, Canada
Start Date
October 1, 2008
Primary Completion Date
December 1, 2013
Completion Date
December 1, 2013
Last Updated
October 26, 2017
48
ACTUAL participants
Lycopene, Vitamin D3, Selenium, Green Tea Extract, Vitamin E
DIETARY_SUPPLEMENT
Placebo
DRUG
Lead Sponsor
University Health Network, Toronto
NCT05691465
NCT04550494
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions